by admin | Sep 1, 2025 | News & Opinions
By Penn Medicine – The ability of a newly understood stem cell originating in skeletal muscle to turn into bone could hold the key to bone healing after catastrophic fractures. When bones break and there is extreme tissue loss—such as after a car accident or a...
by admin | Aug 29, 2025 | News & Opinions
by Michael Gibney – PharmaVoice – The first cell therapy approved by the FDA, Dendreon’s Provenge for prostate cancer, had a bumpy start on the market in 2010, as the autologous treatment was logistically difficult to manufacture and administer, and thus...
by admin | Aug 28, 2025 | News & Opinions
By Sarah Nesbella – Colorado State University – Osteoarthritis (OA) affects over 550 million people worldwide, and there still aren’t effective treatments to stop the continued joint inflammation and cartilage destruction caused by OA. The lifetime...
by admin | Aug 27, 2025 | News & Opinions
By Linda Wang – UCLA Newsroom – Ovarian cancer is the leading cause of death among women with gynecological cancers. The current medical playbook — surgery followed by chemotherapy — initially shows promise. Tumors shrink, sometimes disappearing entirely....
by admin | Aug 26, 2025 | News & Opinions
By Pharmaceutical Technology News – Biostar Stem Cell Technology Research Institute has received the Japanese Ministry of Health, Labour and Welfare (MHLW) approval for its angel stem cell therapy for autism spectrum disorder (ASD). Biostar is jointly operated...
by admin | Aug 25, 2025 | News & Opinions
by Justin Jackson – Phys.org – MedicalXpress – The Institute of Neuroscience, Chinese Academy of Sciences, reports that human stem cell-derived A10-like midbrain dopaminergic neurons integrate into mouse mesocorticolimbic circuits and suppress...
